Electrical pacing therapy for treating mitral regurgitation

• US 20060173504A1
• Filed: 01/28/2005
• Published: 08/03/2006
• Est. Priority Date: 01/28/2005
• Status: Abandoned Application

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Pastore, Joseph M., Zhu, Qingsheng, Salo, Rodney W., Shuros, Allan
• Application Number:
  US11/046,215
• Publication Number:
  US 20060173504A1
• Time in Patent Office: Days
• US Class Current: 607/9
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/3682 with a variable atrioventricular delay
• CPC Class Codes: A61N 1/3684 for stimulating the heart at multiple sites of the ventricle or the atrium
• CPC Class Codes: A61N 1/36842 Multi-site stimulation in the same chamber
• CPC Class Codes: A61N 1/36843 Bi-ventricular stimulation

Abstract

A method and apparatus are disclosed for treating mitral or tricuspid regurgitation with electrical stimulation. By providing pacing stimulation to a selected region of the left ventricle, such as one in proximity to the mitral valve apparatus in a manner which pre-excites the region during early ventricular systole, a beneficial effect is obtained which can prevent or reduce the extent of mitral regurgitation.

Claims

1. A method comprising:

identifying a regurgitant mitral or tricuspid valve in a patient;

implanting a pacing device in the patient for delivering pacing therapy to the heart through one or more pacing electrodes;

monitoring regurgitant flow in the patient; and

,

delivering pacing therapy in a manner which optimally reduces the regurgitant flow.

2. The method of claim 1 further comprising varying the pacing mode while monitoring regurgitant flow and selecting the pacing mode which minimizes the regurgitant flow.

3. The method of claim 1 further comprising varying the placement of the one or more pacing electrodes while monitoring regurgitant flow and selecting the electrode placement which minimizes the regurgitant flow.

4. The method of claim 1 further comprising varying the pacing electrode configuration while monitoring regurgitant flow and selecting the electrode configuration which minimizes the regurgitant flow.

5. The method of claim 1 further comprising varying an AV delay interval while monitoring regurgitant flow and selecting the AV delay interval which minimizes the regurgitant flow.

6. The method of claim 1 further comprising varying a biventricular offset interval while monitoring regurgitant flow and selecting the biventricular offset interval which minimizes the regurgitant flow.

7. The method of claim 1 further comprising:

locating at least one pacing electrode so as to excite a ventricular region in proximity to the regurgitant valve; and

delivering pacing therapy which pre-excites the ventricular region in proximity to the regurgitant valve relative to the rest of the ventricle during ventricular systole.

8. The method of claim 7 further comprising:

measuring an intrinsic AV interval between an atrial sense or pace and a sense in the ventricle with the regurgitant valve; and

,

computing a programmed AV interval which optimally pre-excites the ventricular region in proximity to the regurgitant valve as a function of the measured intrinsic AV interval.

9. The method of claim 7 further comprising pacing the ventricle contralateral to the ventricle with the regurgitant valve at a second programmed AV interval subsequent to an atrial sense or pace.

10. The method of claim 7 further comprising switching between a first pacing mode which pre-excites the ventricular region in proximity to the regurgitant valve relative to the rest of the ventricle during ventricular systole in order to reduce valve regurgitation and a second pacing mode in accordance with a measured physiological variable.

11. An implantable cardiac stimulation device, comprising:

one or more electrodes arranged therein and adapted to be disposed near a cardiac chamber;

pulse generating circuitry coupled to the one or more electrodes and configured to deliver pacing pulses to a cardiac chamber;

sensing circuitry coupled to the one or more electrodes and configured to detect electrical activity from a cardiac chamber;

a controller coupled to the pulse generating and sensing circuitry and configured to control the delivery of pacing pulses; and

,

wherein the controller is programmed to deliver pacing therapy in a manner which optimally reduces the regurgitant flow as determined by monitoring the regurgitant flow while the making adjustments to the pacing therapy delivered by the device.

12. The device of claim 11 wherein the controller is programmed by varying the pacing mode while monitoring regurgitant flow and selecting the pacing mode which minimizes the regurgitant flow.

13. The device of claim 11 wherein the device is configured by varying the placement of the one or more pacing electrodes while monitoring regurgitant flow and selecting the electrode placement which minimizes the regurgitant flow.

14. The device of claim 11 wherein the controller is programmed by varying the pacing electrode configuration while monitoring regurgitant flow and selecting the electrode configuration which minimizes the regurgitant flow.

15. The device of claim 11 wherein the controller is programmed by varying an AV delay interval while monitoring regurgitant flow and selecting the AV delay interval which minimizes the regurgitant flow.

16. The device of claim 11 wherein the controller is programmed by varying a biventricular offset interval while monitoring regurgitant flow and selecting the biventricular offset interval which minimizes the regurgitant flow.

17. The device of claim 11 wherein the device is configured with at least one pacing electrode located so as to excite a ventricular region in proximity to the regurgitant valve, and wherein the controller is programmed to deliver pacing therapy which pre-excites the ventricular region in proximity to the regurgitant valve relative to the rest of the ventricle during ventricular systole.

18. The device of claim 17 wherein the controller is programmed by:

measuring an intrinsic AV interval between an atrial sense or pace and a sense in the ventricle with the regurgitant valve; and

,

computing a programmed AV interval which optimally pre-excites the ventricular region in proximity to the regurgitant valve as a function of the measured intrinsic AV interval.

19. The device of claim 17 wherein the controller is programmed to pace the ventricle contralateral to the ventricle with the regurgitant valve at a second programmed AV interval subsequent to an atrial sense or pace.

20. The device of claim 17 wherein the controller is programmed to switch between a first pacing mode which pre-excites the ventricular region in proximity to the regurgitant valve relative to the rest of the ventricle during ventricular systole in order to reduce valve regurgitation and a second pacing mode in accordance with a measured physiological variable.